All articles

Ozempic and GLP-1 Agonists: The Dark Side of "Miracle Weight Loss Injections"

Ozempic and GLP-1 Agonists: The Dark Side of "Miracle Weight Loss Injections"

in pictures and a few words

What it is and why

Ozempic, Wegovy, Mounjaro and Saxenda are injections for lowering weight and blood sugar. They are man-made twins of the body’s own hormone, only they act much longer.

  • The stomach empties more slowly
  • The brain turns appetite down
  • The pancreas releases more insulin
InjectionQuieter appetiteWeight goes down

What they actually do

In large studies in people, these injections lowered weight noticeably.

  • The result built up over more than a year of treatment
  • In a large study of one of these injections, dangerous heart and blood-vessel events happened less often

Who they are prescribed for

These injections are prescription-only: a doctor prescribes them for clear reasons and keeps an eye on blood tests.

  • Very high excess weight and a high risk for the heart
  • Type 2 diabetes when blood sugar is hard to keep under control
  • When 6–12 months without medicines did not help, or before weight-loss surgery

How treatment starts

The dose is raised in steps, starting small. For once-a-week injections, a new step comes no more often than once every four weeks.

  • Nausea is stronger in the first weeks after a dose increase and usually passes
  • Small portions without fatty or fried food help; eat only until you first feel full
  • With strong nausea, the doctor may postpone the next step
Small doseStep by stepMaintenance dose

Protect your muscles

Along with fat, some muscle goes too. It is worth protecting.

  • Strength training at least twice a week
  • Protein at each of four meals; with a poor appetite, protein powder
  • The doctor can keep track of muscle: measure body composition and grip strength

What else can happen

The injections have other effects too — better to know about them in advance.

  • Fat leaves the face too: cheeks may hollow and folds deepen
  • The stomach may stay slow for a long time — cases have been described even after stopping
  • The regulator looked into a link with suicidal thoughts; people describe a loss of joy

What happens after stopping

If you stop the injections, on average most of the lost weight comes back within a year.

  • Appetite returns, but the body burns less — some muscle is gone
  • That is why protecting muscle during treatment matters so much
Injections stoppedAppetite returnsWeight goes up

Who should see a doctor first

Only a doctor prescribes the injections, after blood tests. Caution with gallstones, severe kidney disease or retina damage from diabetes. They are not prescribed if you have:

  • Medullary thyroid cancer in you or your relatives, or an inherited gland-tumour syndrome
  • Pancreatitis in the past or severely slowed stomach emptying
  • Pregnancy or breastfeeding

Important. Taking warfarin, thyroid hormone, birth control pills, insulin or certain diabetes tablets? Tell your doctor: doses or monitoring change.

When to see a doctor urgently

These signs are a reason to stop the injections immediately and see a doctor right away.

  • Vomiting for more than two days or signs of dehydration
  • Sharp pain in the upper abdomen
  • Jaundice — yellow skin or whites of the eyes
Warning signInjections stoppedStraight to the doctor

Important. Before surgery, anaesthesia or gastroscopy, tell the doctor about the injections: the weekly injection is skipped 7 days before.

In one sentence

These injections lower weight noticeably, but this is prescription treatment: the dose is raised gradually, muscle is protected, and warning signs mean going to a doctor right away.

Frequently asked questions

GLP-1 agonists (Ozempic, Wegovy, Mounjaro) are synthetic analogues of the hormone glucagon-like peptide-1. They slow gastric emptying, suppress appetite in the hypothalamus and stimulate insulin secretion. Semaglutide acts for up to 7 days versus 2 minutes for native GLP-1.

In STEP 1, patients on semaglutide 2.4 mg lost an average of 14.9% of body weight over 68 weeks (Wilding et al., NEJM, 2021). Per Wilding et al. (Diabetes, Obesity and Metabolism, 2022), patients regained approximately 2/3 of the lost weight within one year of discontinuation.

Therapy is justified for BMI above 40 with high cardiovascular risk, poorly controlled type 2 diabetes, or pre-bariatric surgery — the SELECT trial showed a 20% reduction in cardiovascular events. They are contraindicated in MEN 2 and medullary thyroid carcinoma.

Ozempic (up to 2 mg) is for diabetes and Wegovy (2.4 mg) for obesity; both contain the same active substance, semaglutide. Mounjaro (tirzepatide) is a dual GLP-1 and GIP agonist: in SURMOUNT-1 it produced up to 22.5% weight loss.

Resistance training 2–3 times per week, protein 1.4–1.8 g/kg of ideal body weight per day (with BMI > 35, calculated on adjusted weight), DEXA every 6 months. Without these measures, lean mass loss on GLP-1 therapy is virtually guaranteed and accelerates sarcopenia.

The drugs act on weight but do not eliminate insulin resistance, the root cause of obesity. Up to 39% of lost weight is muscle mass, which lowers basal metabolic rate by 5-10%. After stopping, appetite returns while the body burns fewer calories. That is why preserving muscle during therapy matters so much — with resistance training and adequate protein.

Share
Follow on TelegramGet new articles, research updates and practical health tips
Читать на русскомЧитати українською

This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician before making health decisions. Full disclaimer

Ready to Take Action?

A consultation starts where the article ends: your history, your labs, a plan for your case.

Book consultationAsk a question